Price target
10.330.000.00%
The 6 analysts offering 1 year price forecasts for RGLS have a max estimate of — and a min estimate of —.
Analyst rating
Based on 6 analysts giving stock ratings to RGLS in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
RGLS EPS for the last quarter is −0.21 USD despite the estimation of −0.17 USD. In the next quarter EPS is expected to reach −0.20 USD. Track more of Regulus Therapeutics Inc. financials and stay on top of what is up with the company.
In the next quarter Regulus Therapeutics Inc. revenue is expected to reach 0.00 USD. Check out Regulus Therapeutics Inc. revenue and earnings and make informed decisions.
According to analysts, RGLS price target is 10.33 USD with a max estimate of 28.00 USD and a min estimate of 3.00 USD. Check if this forecast comes true in a year, meanwhile watch Regulus Therapeutics Inc. stock price chart and keep track of the current situation with RGLS news and stock market news.
We've gathered opinions of 6 analysts rating RGLS stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.